Cutaneous sarcoidosis is a skin condition that affects up to one third of people with sarcoidosis, a disease that can impact nearly any organ in the body. The skin lesions can take many forms and often provide the first visible clue that something is wrong, making them both a diagnostic challenge and an opportunity for early detection.

Understanding How Common This Condition Is

Cutaneous sarcoidosis is far from rare. It appears in approximately 20 to 35 percent of people who have systemic sarcoidosis, though some studies suggest it may occur in up to one third of all sarcoidosis patients^[1][10][18]. In some cases, skin involvement can happen even without other organ systems being affected, making the skin the only area where the disease shows up^[1].

When looking at sarcoidosis more broadly, the disease affects people worldwide. The incidence is estimated at roughly 16.5 per 100,000 men and 19 per 100,000 women globally^[3]. In the United States, women show a slightly higher lifetime incidence at 1.3 percent compared to 1 percent in men. African Americans experience notably higher rates than Caucasians, with a lifetime incidence of 2.4 percent compared to 0.8 percent^[3].

The condition doesn’t discriminate by age, race, or gender, affecting people from all walks of life. However, certain demographic patterns emerge. Sarcoidosis most commonly appears in adults between 30 and 50 years of age^[4][8]. In Scandinavian countries and Japan, there’s a tendency for the disease to affect both men and women between 25 and 40 years old. Interestingly, in some studies, a second peak of occurrence has been documented in women over 50, though this pattern doesn’t appear consistently across all research^[3].

African Americans and people of Scandinavian descent experience not only higher rates of sarcoidosis but also more severe forms of the disease^[1][4][8]. Older studies also suggest that people of Irish descent may have increased susceptibility^[1][10][18]. The disease appears more frequently in women overall, and surprisingly, it’s more common among non-smokers and people living in rural communities^[4][8].

What Causes This Skin Condition

The underlying cause of cutaneous sarcoidosis, like sarcoidosis in general, remains unknown^[1][10][18]. This mystery has persisted since the disease was first described in the late 1800s by Jonathan Hutchinson, who initially viewed it as a dermatological curiosity^[3]. Despite more than a century of research, scientists still cannot point to a single definitive cause.

What researchers do understand is that sarcoidosis involves the body’s immune system creating granulomas, which are small collections of immune cells that form tight clusters. In sarcoidosis, these are specifically non-caseating granulomas, meaning they don’t have the cheese-like appearance seen in tuberculosis^[4][8]. These granulomas can form in virtually any organ, but when they appear in the skin, they create the various lesions that define cutaneous sarcoidosis.

Current scientific thinking suggests that sarcoidosis develops when someone with genetic vulnerability encounters certain environmental triggers. It appears that an environmental insult—such as exposure to infections, toxins, or heavy fumes—most likely causes sarcoidosis in a genetically susceptible person^[3]. The high incidence among African Americans strongly suggests a genetic component to the disease^[3].

Risk Factors That Increase Your Chances

Several factors appear to increase a person’s risk of developing cutaneous sarcoidosis. Understanding these risk factors helps explain why some people develop the condition while others don’t, though having risk factors doesn’t guarantee someone will develop the disease.

Genetics play a significant role. Scientists have identified eleven specific genetic risk locations associated with sarcoidosis, including genes labeled BTNL2, HLA-B, HLA-DPB1, and several others^[4][8]. Several HLA alleles—which are variations in genes that help the immune system distinguish the body’s own proteins from foreign invaders—are associated with developing the disease. If you’re an identical twin and your twin has sarcoidosis, you face an 80-fold higher risk of also developing the condition^[4][8]. First-degree relatives of African Americans with sarcoidosis also have a notably increased risk^[3].

Environmental exposures appear to matter considerably. People exposed to wood stoves, soil, tree pollen, inorganic particles, insecticides, and silica show increased risk of developing sarcoidosis^[4][8]. Certain occupations have been more frequently associated with the disease, though the exact nature of workplace exposures that trigger it isn’t fully understood. Studies have found that exposure to birds, organic dust, and molds may increase risk^[3].

Some bacteria may act as triggers. Scientists have suggested that Mycoplasma species, Leptospira species, herpes virus, retrovirus, Chlamydia pneumoniae, Borrelia burgdorferi, Pneumocystis jirovecii, and Propionibacterium species might trigger the disease^[4][8]. However, it’s important to understand that these aren’t causes in the traditional sense of infectious disease—they may simply trigger an abnormal immune response in susceptible people.

Interestingly, certain medications can cause reactions that look like sarcoidosis. Drug-induced sarcoidosis-like reactions have been reported with checkpoint inhibitors and various biological agents used to treat other conditions^[4][8]. Additionally, sarcoidosis appears more common in people who also have vitiligo, another immune-related skin condition^[4][8].

Recognizing the Symptoms

Cutaneous sarcoidosis is known as one of the “great imitators” in dermatology because the skin lesions can take so many different forms^[1][10][18]. This makes recognizing the condition challenging, as it can mimic many other skin diseases. The involvement may be mild or severe, short-lived or chronic, and limited to a small area or spread widely across the body^[1][10][18].

Skin lesions are divided into two main categories: nonspecific and specific. Nonspecific lesions occur alongside systemic sarcoidosis but don’t contain granulomas when examined under a microscope. Specific lesions do contain the characteristic non-caseating granulomas^[1][10][18].

Erythema nodosum is the most common nonspecific skin manifestation^[1][10][18]. These lesions appear as extremely tender, red bumps under the skin, often on the front of the lower legs. The onset can be sudden and may come with fever, general feeling of illness, and joint pain. When erythema nodosum appears together with enlarged lymph nodes in the chest and joint pain, it’s called Lofgren’s syndrome, which represents an acute form of systemic sarcoidosis^[1][10][18].

Among specific lesions, papules are the most common type^[1][10][18]. These are small, raised bumps that often appear on the face but can occur anywhere on the body. They might be present as just a few scattered bumps, or they may be numerous and clustered together. The papules can vary in color—they might be red, reddish-brown, purple, translucent, or darker than the surrounding skin. Most feel firm when touched and show little change on their surface.

Plaques are another common presentation. These are larger, flat-topped raised areas on the skin. Like papules, they can appear in various colors and locations. Lupus pernio represents a more serious and chronic form of cutaneous sarcoidosis. These lesions typically appear as violaceous (purple-colored), swollen areas on the nose, cheeks, lips, and ears. Lupus pernio often indicates more severe systemic disease and tends to be particularly difficult to treat.

Scar sarcoidosis is a fascinating phenomenon where sarcoidosis granulomas develop in old scars, even scars that are decades old. This can include surgical scars, injury scars, or even tattoos. The old scar suddenly becomes raised, discolored, or inflamed, which understandably confuses and worries patients.

Rarer forms of cutaneous sarcoidosis include hair loss (alopecia), ulcers, patches of skin that lose their color, and areas of skin that become thick and scaly like fish scales (ichthyosis)^[1][10][18].

Prevention Strategies

Because the exact cause of cutaneous sarcoidosis remains unknown, there are no proven strategies to prevent the condition from developing. Unlike diseases caused by specific infections or behaviors, sarcoidosis appears to result from a complex interaction between genetic predisposition and environmental triggers that scientists don’t yet fully understand.

However, if you’ve been diagnosed with cutaneous sarcoidosis, there are steps you can take to potentially reduce flares and manage your condition. Understanding your personal triggers may help you avoid situations that worsen symptoms, though these triggers vary significantly between individuals.

Since environmental exposures to substances like organic dust, molds, and certain occupational hazards have been associated with increased risk, limiting exposure to these substances might be prudent for those with a family history of sarcoidosis or those already diagnosed. However, it’s important to note that completely avoiding all potential triggers isn’t practical or proven to prevent the disease.

For people with other autoimmune conditions like vitiligo, being aware of the increased association with sarcoidosis means staying alert to new symptoms and maintaining regular healthcare visits. This allows for earlier detection and treatment if sarcoidosis does develop.

How the Disease Changes Your Body

Understanding the pathophysiology—or how the disease changes normal body functions—helps explain why cutaneous sarcoidosis appears and behaves the way it does. At its core, sarcoidosis is a disease of immune system dysfunction, where the body’s defense mechanisms become overactive and create inflammatory clusters where they shouldn’t exist.

The hallmark of sarcoidosis is the formation of non-caseating granulomas. These structures form when immune cells called macrophages gather together in tight, organized clusters. Other immune cells, including T lymphocytes, join these clusters. The term “non-caseating” distinguishes these granulomas from those seen in tuberculosis, which have a different appearance under the microscope^[1][4][8].

When these granulomas form in the skin, they create visible and palpable changes. The clusters of immune cells accumulate in the dermis, which is the deeper layer of skin below the surface layer you can see. As these granulomas grow and multiply, they create the various types of lesions—papules, plaques, and nodules—that characterize cutaneous sarcoidosis.

The immune system response in sarcoidosis appears to be triggered by something the body perceives as foreign, though what that trigger is remains unclear. The body’s immune cells release various chemical messengers called cytokines that promote inflammation. Key players include transforming growth factor beta (TGF-β) and tumor necrosis factor alpha (TNF-α)^[4][8]. These chemical signals recruit more immune cells to the area, perpetuating the inflammatory cycle and causing the granulomas to persist.

In erythema nodosum, the pathophysiology is somewhat different. This represents a hypersensitivity reaction, where the immune system overreacts to a stimulus. Rather than granulomas in the dermis, erythema nodosum involves inflammation in the fatty tissue beneath the skin, a pattern called panniculitis^[1][10][18]. This inflammation causes the characteristic tender, red nodules on the lower legs.

The phenomenon of scar sarcoidosis demonstrates how the disease can lay dormant and then reactivate. The granulomas form specifically in areas of previous tissue damage, suggesting that something about the scar tissue—perhaps altered proteins or persistent inflammation at a microscopic level—attracts the immune response.

Over time, if granulomas persist, they can cause lasting changes to the skin. The clusters of immune cells can disrupt normal skin structures, potentially leading to scarring, permanent color changes, or disfigurement, particularly with chronic lesions like lupus pernio. In some cases, the inflammatory process eventually resolves on its own, and the granulomas disappear, leaving the skin to return toward normal. In other cases, particularly without treatment, the changes become permanent.

The variability in how cutaneous sarcoidosis behaves—sometimes resolving spontaneously, sometimes persisting for years—reflects the unpredictable nature of the underlying immune dysfunction. Some people experience only a brief period of immune system overactivity before it naturally calms down. Others have persistent immune dysregulation that requires ongoing management to prevent progressive damage.